Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MLXIPL anticorps (AA 50-150)

MLXIPL Reactivité: Humain, Souris WB, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN540822
  • Antigène Voir toutes MLXIPL Anticorps
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Épitope
    • 15
    • 14
    • 7
    • 7
    • 6
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 50-150
    Reactivité
    • 44
    • 25
    • 14
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Humain, Souris
    Hôte
    • 56
    • 3
    Lapin
    Clonalité
    • 56
    • 3
    Polyclonal
    Conjugué
    • 26
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MLXIPL est non-conjugé
    Application
    • 35
    • 20
    • 20
    • 13
    • 13
    • 10
    • 9
    • 9
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of MLXIPL.
    Specificité
    This antibody is specific to ChREBP.
     Réactivité croisée
    Humain, Souris
    Attributs du produit
    Antibody Reactive Against Synthetic Peptide.
    Immunogène
    A synthetic peptide corresponding to amino acids 50-150 of human MLXIPL.
    Top Product
    Discover our top product MLXIPL Anticorps primaire
  • Indications d'application
    Immunofluorescence (1:100-1:500)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.01 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store at 4°C. Do not freeze.
  • Iizuka, Bruick, Liang, Horton, Uyeda: "Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 19, pp. 7281-6, (2004) (PubMed).

    Letexier, Pinteur, Large, Fréring, Beylot: "Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue." dans: Journal of lipid research, Vol. 44, Issue 11, pp. 2127-34, (2003) (PubMed).

    Yamashita, Takenoshita, Sakurai, Bruick, Henzel, Shillinglaw, Arnot, Uyeda: "A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 16, pp. 9116-21, (2001) (PubMed).

  • Antigène
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Autre désignation
    MLXIPL (MLXIPL Produits)
    Synonymes
    anticorps ChREBP, anticorps MLXIPL, anticorps CHREBP, anticorps MIO, anticorps MONDOB, anticorps WBSCR14, anticorps WS-bHLH, anticorps bHLHd14, anticorps Wbscr14, anticorps MLX interacting protein-like, anticorps MLX interacting protein like, anticorps MLXIPL, anticorps Mlxipl
    ID gène
    51085
    Pathways
    Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Vous êtes ici:
Support technique